Skip to main content
JAYSYNTH ORGOCHEM LIMITED logo

JAYSYNTH ORGOCHEM LIMITED — Investor Relations & Filings

Ticker · 524592 ISIN · INE263B01022 LEI · 335800ZE9HI681C1KV23 BSE.NS Manufacturing
Open in API
Filings indexed 6 across all filing types
Latest filing 2026-05-27 Regulatory Filings
Country IN India
Listing BSE.NS 524592

About JAYSYNTH ORGOCHEM LIMITED

https://www.jaysynth.com

Jaysynth Orgochem Limited specializes in the manufacturing and distribution of synthetic organic dyes, pigments, and digital printing inks. The company provides a comprehensive range of colorant solutions, including reactive dyes, disperse dyes, and acid dyes tailored for the textile, leather, and paper sectors. A significant focus of its operations is the development of advanced digital textile printing inks under its proprietary brands, catering to the evolving needs of the global printing market. With a commitment to research and development, the firm emphasizes high-performance products, color consistency, and technical support. Its portfolio serves diverse applications ranging from traditional dyeing processes to modern industrial digital printing, maintaining a strong presence in both domestic and international markets through a robust supply chain and quality-driven manufacturing processes.

Recent filings

Filing Released Lang Actions
Proposed Incorporation of a Wholly owned subsidiary (WOS)
Regulatory Filings Classification · 47% confidence The document is an exchange filing under Regulation 30 of SEBI LODR, notifying the board’s approval to incorporate a wholly owned subsidiary in Hong Kong along with required disclosure annexure. It is an announcement-type regulatory filing rather than the substantive report itself or an earnings release. It does not fit the narrow ‘share issue’ or ‘financing’ categories in a material way but is a routine compliance announcement. Therefore it falls under General Regulatory Filings (RNS).
2026-05-27 English
Appointment of Internal Auditor
Regulatory Filings Classification · 90% confidence The document is a stock‐exchange disclosure under SEBI LODR Regulation 30 announcing the board’s approval to appoint an internal auditor. It contains no financial statements, management discussion, or detailed report; instead it is a compliance/regulatory announcement. This does not fit financial result releases or management/board changes (auditor isn’t senior management or director) but is a general regulatory filing. Therefore it is best classified as Regulatory Filings (RNS).
2026-05-27 English
Recommendation of Dividend
Notice of Dividend Amount Classification · 93% confidence The document is an official stock exchange notice by the company’s Board of Directors recommending a dividend for the financial year ended 31 March 2026, including the specific dividend rates per share. This is a direct announcement of dividend amounts for shareholders (subject to AGM approval), matching the definition of a Notice of Dividend Amount (DIV).
2026-05-27 English
Audited Financial Results for the quarter and financial year ended 31st March 2026
Interim / Quarterly Report Classification · 85% confidence The document is a SEBI (Listing Obligations) Regulation 33 submission of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2026. It includes full P&L tables, segment reporting, statements of assets & liabilities and cashflows. This is a comprehensive interim/quarterly report filing (not just a brief earnings highlight or a publication notice), so it fits the definition of an Interim / Quarterly Report (IR). FY 2026
2026-05-27 English
Outcome of Board Meeting
Regulatory Filings Classification · 82% confidence The document is a notice under SEBI LODR Regulation 30 informing the stock exchange of board resolutions (approval of audited financial results, appointment of internal auditor, subsidiary incorporation, dividend recommendation, etc.). It does not contain the actual financial data, nor is it a detailed report or presentation; it is a standard regulatory announcement of meeting outcomes. This fits the ‘Regulatory Filings’ fallback category (RNS).
2026-05-27 English
Jaysynth Orgochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated ....
Regulatory Filings Classification · 84% confidence The document is a notice sent to the stock exchange under SEBI Listing Regulations (Reg. 29 and 33) announcing the date of a Board meeting to consider and approve audited standalone and consolidated financial results. It does not contain the financial results themselves, nor is it a management change or dividend notice, nor a full report; rather it is a general regulatory announcement. Therefore it falls under the Regulatory Filings (RNS) category.
2026-05-18 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.